The EFS Executive Steering Committee is the overarching body within MDIC’s EFS initiative. Comprised of industry leaders, regulatory experts, and clinical specialists, this committee plays a role in advancing medical device innovation in the United States.
The EFS Executive Steering Committee contributes to the advancement of the EFS program through strategic guidance and oversight:
Back MDIC’s efforts in tracking EFS performance metrics and developing tools and best practices for EFS sponsors and clinical researchers.
Foster interaction among the FDA, sponsors, and innovators during the early stages of product development.
Support initiatives aimed at streamlining the EFS process, potentially reducing time and resource constraints for US-based studies.
The EFS Executive Steering Committee aims to provide valuable resources to individuals interested in participating in EFS. These resources can be found in the Accelerate EFS Toolkit and are designed to improve the efficiency of the EFS contracting process and enhance patients’ understanding of early-stage clinical trials.